3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1/2
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Myeloproliferative Disorders
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Graft vs Host Disease
1
Interventions
Methotrexate
10
Cyclophosphamide
8
Cyclosporine
6
Tacrolimus
4
Mycophenolic Acid
4
Sirolimus
3
Antilymphocyte Serum
3
fludarabine
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Pentostatin
2
Methylprednisolone
2
Cyclosporins
2
Busulfan
2
trihexyltetradecylphosphonium chloride
1
thymoglobulin
1
ruxolitinib
1
merphos
1
ibrutinib
1
fludarabine phosphate
1
aldesleukin
1
Whole-Body Irradiation
1
Thiotepa
1
Therapeutics
1
Rituximab
1
Proto-Oncogene Proteins c-raf
1
Prednisone
1
Photopheresis
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Graft vs Host Disease
×
Calcineurin Inhibitors
×
Clear all
NCT01749111
2017-03-03
CICLODECH
Hospital Israelita Albert Einstein
Phase 3
Terminated
3 enrolled